Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Azenta, Inc. (AZTA) PT Lowered to $115 at Needham & Company
February 9, 2022 6:59 AM ESTNeedham & Company analyst David Saxon lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $115.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "AZTAs F1Q22 revenue and EPS beat consensus and management provided F2Q22 revenue and EPS guidance that... More
Azenta, Inc. (AZTA) Tops Q1 EPS by 4c
February 8, 2022 4:07 PM ESTAzenta, Inc. (NASDAQ: AZTA) reported Q1 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $140 million versus the consensus estimate of $135.42 million.
GUIDANCE:
Azenta, Inc. sees Q2 2022 EPS of $0.07-$0.15, versus the consensus of... More
